Lines of investigation
Research lines of our laboratory are focused on the identification of genes and proteins implicated in the occurrence and development of psychiatric (anxiety, depression, substance use, post-traumatic stress, etc.) and neurological (Parkinson´s disease, Alzheimer´s disease, etc.) disorders, which can be relevant for the discovery of new therapeutic targets to improve its pharmacological management.
For that purpose, we employ validated animal models of the psychiatric and neurological disorders that we want to study. These animal models must be able to reproduce, at least in part, certain behavioural traits and/or neurobiological features of the illnesses that they are simulating. Thus, the objective is to enhance the translational capacity of animal modelization that allows for applying the results to the patient.
The improvement of our knowledge about the alterations implicated in the aetiology and the development of different psychiatric and neurological disorders is one of our main goals, closely related with the discovery of more effective and safer pharmacological approaches. In the last years, we are focused on the role of the endocannabinoid system in the regulation of different brain functions and its potential pharmacotherapeutic exploitation. To this aim, we are very interested in the behavioural and neurochemical effects of genetic or pharmacological manipulation of the endocannabinoid system, employing transgenic animal models or cannabinoid compounds, respectively.
In our studies, we design and perform experiments to evaluate behavioral features related with emotional (anxiety, depression, stress, etc.) and cognitive (prepulse inhibition, memory impairment, etc.) alterations, and with the reinforcing and motivational effects of drugs of abuse (alcohol, cocaine, etc.). Furthermore, to evaluate the neurochemical changes that could be related with behaviour, we analyse gene expression of key targets by real time PCR or in situ hybridization experiments, as well as protein expression by immunohistochemistry or Western Blot techniques.
Laboratory members have a long-lasting and continuous relationship with several groups of psychiatrists and neurologists. This fact has significantly contributed to establish a reciprocal bridge of information between preclinical and clinical research, which has been reflected in several joint publications. Our objective is to maintain and to strengthen this type of collaborative strategies aimed to encourage translational research and finally improve the quality of life of psychiatric and neurological patients.
Representative Publications
- Behavioral and Brain Gene and Protein Changes in Female Mice Consuming Ethanol During Pregnancy and Lactation. Daniela Navarro, Francisco Navarrete ,Nerina Villalba , Abraham B Torregrosa , Laura Caltana ,Ani Gasparyan,, Alicia Brusco, Jorge Manzanares. Biomolecules. 2025 15(9): 1239 https://doi.org/10.3390/biom15091239
- Alterations of pro- and anti-inflammatory cytokines balance and superoxide dismutase in the dorsolateral prefrontal cortex of suicide decedents. María S García-Gutiérrez , Esther Caparros, Abraham B Torregrosa, Sebastián Martínez-López , Ani Gasparyan,Salvador Giner , Jorge Manzanares Neurotherapeutics. 2025 22(5) :e00634 https://doi.org/10.1016/j.neurot.2025.e00634
- MCH11, a new monoacylglycerol lipase inhibitor, reduces ethanol consumption and motivation to drink in mice, with sex-dependent differences. Torregrosa A B, García-Gutiérrez MS, Navarro D, Navarrete F and Manzanares J. Biomedicine & Pharmacotherapy. 2025 192: 118662 https://doi.org/10.1016/j.biopha.2025.118662
- Whole transcriptome analysis of peripheral blood mononuclear cells from de novo and drug-naïve Parkinson’s disease patients. Navarrete F, Guillot-Fernández M, Martínez-Hostyn L, Navarro D, Molina J A, López-Atalaya J P and Manzanares J. Neurotherapeutics. 2025 e00762 https://doi.org/10.1016/j.neurot.2025.e00762
- ESTraS, an easy and simple tracking system for assessing rodent behavior. A. Morcuende, T. Femenía, J. Manzanares & A. Gasparyan. Behav Res. 2025 57; article number 90 https://doi.org/10.3758/s13428-024-02537-7
- Editorial: Methylation in the human brain. Sheila T. Nagamatsu, Francisco Navarrete, Maria S. Garcia-Gutierrez. Front. Genet. 2025 Sec. Behavioral and Psychiatric Genetics; Volume 16 https://doi.org/10.3389/fgene.2025.1589816
- Changes in neurobiological markers of reactivity to alcohol-related stimuli in alcohol-dependent patients after two years of treatment. Gabriel Rubio, Marta Marín, Cristina Martín-Arriscado Arroba, Enrique Rubio-Escobar, Francisco Arias, Abraham B. Torregrosa, Jorge Manzanares. Front. Psychiatry. 2025 Volume 16 - Sec. Addictive Disorders https://doi.org/10.3389/fpsyt.2025.1613169
- A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders. María S. García-Gutiérrez , Abraham B. Torregrosa, Francisco Navarrete, Daniela Navarro , Jorge Manzanares Pharmacological Research. 2025 213: 107657 https://doi.org/10.1016/j.phrs.2025.107657
- Fetal Cannabinoid Syndrome: Behavioral and Brain Alterations of the Offspring Exposed to Dronabinol during Gestation and Lactation. Daniela Navarro, Ani Gasparyan, Francisco Navarrete and Jorge Manzanares. Int. J. Mol. Sci. 2024 25(13), 7453 https://doi.org/10.3390/ijms25137453
- Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality. Antonio J Carrascosa, Francisco Navarrete , Raquel Saldaña María S García-Gutiérrez, Belinda Montalbán , Daniela Navarro, Fernando M Gómez-Guijarro, Ani Gasparyan, Elena Murcia-Sánchez , Abraham B Torregrosa, Paloma Pérez-Doblado, Luisa Gutiérrez, Jorge Manzanares. Int J Mol Sci. 2024 25(11): 6268 https://doi.org/10.3390/ijms25116268
Español